Back to NBIX

Vestal Point Capital, LP → NBIX

Vestal Point Capital, LP NBIX Position History

Neurocrine Biosciences, Inc. • Healthcare

Quarters held
3
Latest value
$354.6M
Q3 2026
Peak value
$354.6M
First seen
Q1 2026

Dollar value over time

Show data table
PeriodPosition value
Q1 2026$164.7M
Q2 2026$316.8M
Q3 2026$354.6M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$354.6M2.50M——
Q2 2026$316.8M1.88M——
Q1 2026$164.7M1.25M——

Other funds holding NBIX

Other Vestal Point Capital, LP positions

AAVXF

Abivax SA

$392.1M
BMRN

BioMarin Pharmaceutical Inc

$344.8M
BMRN

BioMarin Pharmaceutical Inc

$331.5M
ARWR

Arrowhead Pharmaceuticals Inc

$315.1M
AAVXF

Abivax SA

$313.1M
INSM

Insmed Inc

$311M
UTHR

United Therapeutics Corp

$257.4M
AAVXF

Abivax SA

$256.2M